Clinical Trial Update: Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir [Phase 1]

View source ↗

Summary

Phase 1 study examining pharmacokinetic interactions between telaprevir and un-boosted atazanavir in adults with chronic hepatitis C and HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Incivek (telaprevir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Hospitales Universitarios Virgen del Rocío | Conditions: Hepatitis C, Chronic, HIV Infection | Phase 1 | Status: COMPLETED